Dara Biosciences Inc (NASDAQ:DARA)

CAPS Rating: 2 out of 5

Results 1 - 3 of 3

Recs

2
Member Avatar zzlangerhans (99.78) Submitted: 4/2/2014 7:55:54 PM : Outperform Start Price: $2.74 DARA Score: -64.27

I could easily have red thumbed Dara if the stock had continued to rise on irrational exuberance related to Orphan Drug designation for KRN5500. Instead, hyperactive momo traders dumped the stock to look for more muppet bait. Meanwhile, Dara continues to derive all operational funding from dilution rather than product sales. Can the recidivist Dara hypers start working the bellows again? I'm sure they can.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 2/19/2014 5:53:26 AM : Outperform Start Price: $2.63 DARA Score: -64.35

DARA r/s split play

Recs

0
Member Avatar mbates50 (< 20) Submitted: 1/24/2013 5:35:37 PM : Outperform Start Price: $4.60 DARA Score: -108.25

gut feeling only.

Results 1 - 3 of 3

Featured Broker Partners


Advertisement